Designates Xylazine as a schedule III depressant.
Designates Xylazine as a schedule III depressant.
Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the federal food and drug administration.
Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the federal food and drug administration.
Prohibits the sale of infant inclined sleepers; restricts the use of such inclined sleepers in certain settings.
Relates to the schedules that work act.
Relates to the schedules that work act.
Adds certain substances already listed under 21 U.S.C. Section 812 to the schedules of controlled substances.
Adds certain substances already listed under 21 U.S.C. Section 812 to the schedules of controlled substances.
Relates to the scheduling of a fact finding hearing after the issuance of a temporary order of protection in family court; provides that such hearing shall be scheduled no later than 14 days after the temporary order is issued.